Was the immunoadjuvant IL-33 utilized in P1 VGX-3100 study or was this added during the P2 study of VGX-3100? I didn't see anything in the peer reviewed article (STM) talk about immunoadjuvant IL-33 in the study unless I'm missing it somewhere.
Thanks KR for keeping us in the know. The only catalysts I have at the present are putting away some old British roadsters for the Minnesota winter, and gearing up for the launch of the INO Millionaires Club. Will keep you all posted.
If they're saying anything new in Barcelona, it'll get PR'd first. That presentation is noonish EST. The two dollar doldrums could be coming to an end in the morning. Short Ribs for lunch? GLTlongs.